Targeting autophagy addiction may be helpful incircumventing the primary resistance to HER2 targeting therapies and may potentiate the efficacy ofHER2 targeting strategies currently in use in HER2-positive breast cancer patients. Here, ERBB2 is linked to breast carcinoma.